158 related articles for article (PubMed ID: 25193618)
21. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
[TBL] [Abstract][Full Text] [Related]
22. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
Lundy JJ; Coons SJ; Aaronson NK
Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
[TBL] [Abstract][Full Text] [Related]
23. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
[TBL] [Abstract][Full Text] [Related]
24. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
25. Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany.
Dirmaier J; Zaun S; Koch U; Harfst T; Schulz H
Palliat Support Care; 2004 Jun; 2(2):115-24. PubMed ID: 16594241
[TBL] [Abstract][Full Text] [Related]
26. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
[TBL] [Abstract][Full Text] [Related]
27. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
[TBL] [Abstract][Full Text] [Related]
28. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
[TBL] [Abstract][Full Text] [Related]
30. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
31. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
32. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
33. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
34. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
[TBL] [Abstract][Full Text] [Related]
35. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
[TBL] [Abstract][Full Text] [Related]
36. Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses.
Scott NW; Fayers PM; Bottomley A; Aaronson NK; de Graeff A; Groenvold M; Koller M; Petersen MA; Sprangers MA;
Qual Life Res; 2006 Aug; 15(6):1103-15; discussion 1117-20. PubMed ID: 16900290
[TBL] [Abstract][Full Text] [Related]
37. Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients.
Dirven L; Groenvold M; Taphoorn MJB; Conroy T; Tomaszewski KA; Young T; Petersen MA;
Qual Life Res; 2017 Nov; 26(11):2919-2929. PubMed ID: 28707048
[TBL] [Abstract][Full Text] [Related]
38. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
39. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
40. Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.
Coon CD; Schlichting M; Zhang X
Patient; 2022 Nov; 15(6):691-702. PubMed ID: 35771392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]